[HTML][HTML] Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation

N Lindson, SC Chepkin, W Ye… - … of systematic reviews, 2019 - ncbi.nlm.nih.gov
Background Nicotine replacement therapy (NRT) aims to replace nicotine from cigarettes to
ease the transition from cigarette smoking to abstinence. It works by reducing the intensity of …

Nicotine receptor partial agonists for smoking cessation

K Cahill, N Lindson‐Hawley… - Cochrane database …, 2016 - cochranelibrary.com
Background Nicotine receptor partial agonists may help people to stop smoking by a
combination of maintaining moderate levels of dopamine to counteract withdrawal …

Smoking cessation in chronic obstructive pulmonary disease

DP Tashkin - Seminars in respiratory and critical care medicine, 2015 - thieme-connect.com
Smoking cessation is the most effective strategy for slowing down the progression of chronic
obstructive pulmonary disease (COPD) and reducing mortality in the approximately 50% of …

Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial

HE Tulloch, AL Pipe, C Els, MJ Clyde, RD Reid - BMC medicine, 2016 - Springer
Background Extended use of combined pharmacotherapies to treat tobacco dependence
may increase smoking abstinence; few studies have examined their effectiveness. The …

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation

A Theodoulou, SC Chepkin, W Ye… - Cochrane Database …, 2023 - cochranelibrary.com
Background Nicotine replacement therapy (NRT) aims to replace nicotine from cigarettes.
This helps to reduce cravings and withdrawal symptoms, and ease the transition from …

A bidirectional path analysis model of smoking cessation self‐efficacy and concurrent smoking status: Impact on abstinence outcomes

M Clyde, A Pipe, R Reid, C Els, H Tulloch - Addiction biology, 2019 - Wiley Online Library
Self‐efficacy is routinely associated with abstinence in the addictions literature, and is a
major component relapse‐prevention models. The magnitude of this relationship has been …

Nicotine receptor partial agonists for smoking cessation

J Livingstone-Banks, TR Fanshawe… - Cochrane Database …, 2023 - cochranelibrary.com
Background Nicotine receptor partial agonists may help people to stop smoking by a
combination of maintaining moderate levels of dopamine to counteract withdrawal …

[HTML][HTML] The quit experience and concerns of smokers with psychiatric illness

HE Tulloch, AL Pipe, MJ Clyde, RD Reid… - American Journal of …, 2016 - Elsevier
Introduction The purpose of this study is to better understand the quit experience and
concerns of smokers with psychiatric illness (ie, major depressive, anxiety, psychotic and …

[PDF][PDF] Smoking cessation in COPD patients by a selective partial nicotinic agonist

ES Ianosi, P Postolache, LA Macovei, M Szathmary… - Rev Chim, 2018 - bch.ro
The fight against smoking through various smoking cessation methods could be very
effective by early education especially in young people for preventing the occurrence or the …

Task and barrier self-efficacy among treatment-seeking smokers with current, past or no psychiatric diagnosis

M Clyde, H Tulloch, R Reid, C Els, A Pipe - Addictive Behaviors, 2015 - Elsevier
Objective Individuals with a lifetime diagnosis of mental illness smoke at rates greater than
the general population, and have more difficultly quitting. Cessation self-efficacy has been …